@maximemax606 $SIVE up 1540% TTM with two dilutive raises in 8 months and analyst PT 88% below current price. Math says buyers now are the exit liquidity.
@asianinvestors@NemCapSE If youβre up 800% time to rotate. $SIVE up 1540% TTM with two dilutive raises in 8 months and analyst PT 88% below current price. Math says youβre the exit liquidity.
@NingiResearch $SIVE up 1540% TTM with two dilutive raises in 8 months and analyst PT 88% below current price. Math says buyers now are the exit liquidity.
@QC_Capitals π¨ Monopoly drug for a fatal rare disease.
Zero competition. Near-zero debt.
38% of market cap in cash.
Trading at just 5x earnings β with EU approval pending.
$ZVRA is a gift.
High-conviction rare disease play with massive upside. DYOR.
At the moment would touch any of them. The fwd peβs are crazy.
π₯ $SOFI vs $HOOD head-to-head
Forward P/E: SOFI 26x vs HOOD 36x
Revenue growth: SOFI +41% vs HOOD +15%
Debt/Equity: SOFI 0.18x vs HOOD 1.40x
Platform assets: SOFI $40B deposits (bank) vs HOOD $307B AUM (brokerage)*
More growth. Cheaper multiple. Cleaner balance sheet β $SOFI
Bigger platform, higher margins, covered call optionality β $HOOD
Different animals. Pick your thesis.
*Deposits β brokerage AUM
Not financial advice. DYOR.
π¨ $SIVE alert β not a buy call
Stock up 37x in 12 months. Trading at 70-90x revenue. Losing money. Cash runway ~3 quarters. Analyst PTs: SEK 6-10. Stock at SEK 90+.
Largest shareholder in debt restructuring β forced seller incoming.
GlobalFoundries partnership is real. The valuation is not.
Pipeline β revenue.
Not financial advice. DYOR.
I would get out while you can
π¨ $SIVE alert β not a buy call
Stock up 37x in 12 months. Trading at 70-90x revenue. Losing money. Cash runway ~3 quarters. Analyst PTs: SEK 6-10. Stock at SEK 90+.
Largest shareholder in debt restructuring β forced seller incoming.
GlobalFoundries partnership is real. The valuation is not.
Pipeline β revenue.
Not financial advice. DYOR.
@hennycapital $MRVL just ripped +32% to new all-time high after Jensen Huang called it the next trillion-dollar company.
Thesis remains 100% alive.
Wait for the $220 entry.
π Lead β donβt chase. Patience wins
#$mrvl
π¨ $SIVE alert β not a buy call
Stock up 37x in 12 months. Trading at 70-90x revenue. Losing money. Cash runway ~3 quarters. Analyst PTs: SEK 6-10. Stock at SEK 90+.
Largest shareholder in debt restructuring β forced seller incoming.
GlobalFoundries partnership is real. The valuation is not.
Pipeline β revenue.
Not financial advice. DYOR.
π¨ $SIVE alert β not a buy call
Stock up 37x in 12 months. Trading at 70-90x revenue. Losing money. Cash runway ~3 quarters. Analyst PTs: SEK 6-10. Stock at SEK 90+.
Largest shareholder in debt restructuring β forced seller incoming.
GlobalFoundries partnership is real. The valuation is not.
Pipeline β revenue.
Not financial advice. DYOR.
π¨ $SIVE alert β not a buy call
Stock up 37x in 12 months. Trading at 70-90x revenue. Losing money. Cash runway ~3 quarters. Analyst PTs: SEK 6-10. Stock at SEK 90+.
Largest shareholder in debt restructuring β forced seller incoming.
GlobalFoundries partnership is real. The valuation is not.
Pipeline β revenue.
Not financial advice. DYOR.
π¨ $SIVE alert β not a buy call
Stock up 37x in 12 months. Trading at 70-90x revenue. Losing money. Cash runway ~3 quarters. Analyst PTs: SEK 6-10. Stock at SEK 90+.
Largest shareholder in debt restructuring β forced seller incoming.
GlobalFoundries partnership is real. The valuation is not.
Pipeline β revenue.
Not financial advice. DYOR.
π¨ $SIVE alert β not a buy call
Stock up 37x in 12 months. Trading at 70-90x revenue. Losing money. Cash runway ~3 quarters. Analyst PTs: SEK 6-10. Stock at SEK 90+.
Largest shareholder in debt restructuring β forced seller incoming.
GlobalFoundries partnership is real. The valuation is not.
Pipeline β revenue.
Not financial advice. DYOR.